Tirzepatide Enhances Blood Sugar Regulation in Adolescents with Type 2 Diabetes Unresponsive to Current Treatments (SURPASS-PEDS Trial)
New findings from a landmark phase 3 clinical trial reveal that tirzepatide, a novel dual GIP/GLP-1 receptor agonist, yields significant ...
